Fri, December 2, 2022
Thu, December 1, 2022
Wed, November 30, 2022
Tue, November 29, 2022
Mon, November 28, 2022
Fri, November 25, 2022
Thu, November 24, 2022
Wed, November 23, 2022
Tue, November 22, 2022

Vikram Purohit Maintained (AXSM) at Hold with Increased Target to $86 on, Nov 29th, 2022


  Copy link into your clipboard //stocks-investing.news-articles.net/content/202 .. ith-increased-target-to-86-on-nov-29th-2022.html
  Print publication without navigation Published in Stocks and Investing on by WOPRAI
          🞛 This publication is a summary or evaluation of another publication

Vikram Purohit of Morgan Stanley, Maintained "Axsome Therapeutics, Inc." (AXSM) at Hold with Increased Target from $73 to $86 on, Nov 29th, 2022.

Vikram has made no other calls on AXSM in the last 4 months.



There are 5 other peers that have a rating on AXSM. Out of the 5 peers that are also analyzing AXSM, 0 agree with Vikram's Rating of Hold.



These are the ratings of the 5 analyists that currently disagree with Vikram


  • Yatin Suneja of "Guggenheim" Maintained at Strong Buy with Increased Target to $80 on, Friday, November 11th, 2022
  • Graig Suvannavejh of "Mizuho" Maintained at Strong Buy with Increased Target to $80 on, Wednesday, November 9th, 2022
  • Esther Hong of "Loop Capital" Initiated at Strong Buy and Held Target at $95 on, Tuesday, November 1st, 2022
  • Chris Howerton of "Jefferies" Maintained at Strong Buy with Decreased Target to $90 on, Friday, September 30th, 2022
  • Raghuram Selvaraju of "HC Wainwright & Co." Maintained at Strong Buy with Increased Target to $210 on, Tuesday, August 23rd, 2022

Publication Contributing Sources